Inactive Instrument

Procter & Gamble Health Ltd Stock price NSE India S.E.

Equities

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR 0.00% Intraday chart for Procter & Gamble Health Ltd
Sales 2022 11.14B 134M Sales 2023 12.3B 148M Capitalization 87.13B 1.05B
Net income 2022 1.92B 23.1M Net income 2023 2.3B 27.54M EV / Sales 2022 5.95 x
Net cash position 2022 3.17B 37.99M Net cash position 2023 4.23B 50.77M EV / Sales 2023 6.74 x
P/E ratio 2022
36.1 x
P/E ratio 2023
38 x
Employees -
Yield 2022
1.25%
Yield 2023
1.81%
Free-Float 47.83%
More Fundamentals * Assessed data
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Procter & Gamble Hygiene to Discontinue Injection Production at Goa, Unit, India MT
Procter & Gamble Health Limited Discontinues Production of Injections at its Manufacturing Plant in Goa Effective September 30, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
Procter & Gamble Health Limited Announces Change in Senior Management Personnel CI
Procter & Gamble India to invest $244 million to set up manufacturing facility RE
Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Procter & Gamble Health Appoints CFO MT
Procter & Gamble Health Limited Appoints Lokesh Chandak as Chief Financial Officer, Effective April 1, 2023 CI
Procter & Gamble Health's CFO Resigns MT
Procter & Gamble Health Limited Announces Board Changes CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Executive Director, Effective March 31, 2023 CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Chief Financial Officer, Effective March 31, 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer 55 18-03-31
Director of Finance/CFO - 23-03-31
Compliance Officer - 21-06-30
Members of the board TitleAgeSince
Chairman 86 84-01-16
Director/Board Member 66 21-11-14
Director/Board Member 75 15-02-04
More insiders
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
More about the company
  1. Stock
  2. Equities
  3. Stock Procter & Gamble Health Limited
  4. Stock Procter & Gamble Health Ltd - NSE India S.E.